CELATOR PHARMACEUTICALS INC

PRINCETON, NJ How do I update this listing?

Celator Pharmaceuticals is based out of Princeton. Celator Pharmaceuticals, Inc. develops and produces advance biopharmaceutical products. The company researches and distributes therapies to treat cancer, leukemia, and small cell lung cancer through the proper regulation of chemotherapy. Celator Pharmaceuticals serves customers throughout the United States and Canada.Whalewisdom has at least 61 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2013-05-13. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

celator pharmaceuticals inc
303B COLLEGE ROAD EAST
PRINCETON NJ    08540

Business Phone: (609) 243-0123
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2013-05-13 D/A PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 39,262,788 39,262,788 0
2012-08-30 D PHARMACEUTICALS Equity 35,000,000 4,148,617 30,851,383
2011-12-28 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,000,500 2,576,867 2,423,633
2010-09-07 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 20,000,003 15,000,001 5,000,002
2010-05-10 D PHARMACEUTICALS Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 2,500,000 2,500,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALEX ZISSON subscription required
    DIRECTOR
BRENDA D. GAVIN subscription required
    DIRECTOR
BRENDA D GAVIN, D.V.M. subscription required
    DIRECTOR
DAVID WOOD subscription required
    EXECUTIVE OFFICER
FRED M. POWELL subscription required
    EXECUTIVE OFFICER
J. KEVIN BUCHI subscription required
    DIRECTOR
JACKSON T. SCOTT subscription required
    EXECUTIVE OFFICER DIRECTOR
JOSEPH A. MOLLICA subscription required
    DIRECTOR
JOSEPH A. MOLLIICA, PH.D. subscription required
    DIRECTOR
KENNETH GALBRAITH subscription required
    DIRECTOR
LAWRENCE D. MAYER subscription required
    EXECUTIVE OFFICER DIRECTOR
NICOLE VITULLO subscription required
    DIRECTOR
PATRICK BRADY subscription required
    DIRECTOR
RICHARD S. KOLLENDER subscription required
    DIRECTOR
SCOTT JACKSON subscription required
    EXECUTIVE OFFICER DIRECTOR
SCOTT MORENSTEIN subscription required
    DIRECTOR

Elevate your investments